|
|
|
Volumn 42, Issue 11, 2017, Pages 673-683
|
|
Pharmaceutical approval update
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOLEVULINIC ACID;
AZTREONAM;
CARBAMAZEPINE;
DELAFLOXACIN;
EFAVIRENZ;
GLECAPREVIR;
MAVYRET;
PIBRENTASVIR;
PORPHYRIN;
VANCOMYCIN;
ALLERGIC REACTION;
ANAPHYLAXIS;
ANTIVIRAL ACTIVITY;
ARTICLE;
BACTERIAL INFECTION;
CELLULITIS;
CHILL;
CLOSTRIDIUM DIFFICILE INFECTION;
DERMATITIS;
DIARRHEA;
DRUG APPROVAL;
END STAGE RENAL DISEASE;
ENTEROBACTER CLOACAE;
ENTEROCOCCUS FAECALIS;
ESCHERICHIA COLI;
ESTIMATED GLOMERULAR FILTRATION RATE;
FEVER;
FLUORESCENCE IMAGING;
GLIOMA;
HEMIANOPIA;
HEMIPARESIS;
HEMIPLEGIA;
HEPATITIS B VIRUS;
HEPATITIS C VIRUS;
HUMAN;
HYPERSENSITIVITY;
HYPESTHESIA;
HYPOTENSION;
INFLAMMATION;
KLEBSIELLA PNEUMONIAE;
LIVER CIRRHOSIS;
LIVER FUNCTION TEST;
MILD RENAL IMPAIRMENT;
MYASTHENIA GRAVIS;
NAUSEA;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PORPHYRIA;
PSEUDOMONAS AERUGINOSA;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SEIZURE;
SKIN ABSCESS;
SKIN INFECTION;
STAPHYLOCOCCUS;
STREPTOCOCCUS;
SWELLING;
URTICARIA;
VOMITING;
WOUND INFECTION;
|
|
EID: 85032959368
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|
